|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 曲妥珠单抗联合化疗与单纯化疗治疗HER2阳性晚期胃或胃食管结合部癌的Ⅲ期、开放、随机对照临床试验(ToGA试验)显示文摘 | Van Cutsem E Feyereislova A 张信华 | 2010 | 消化肿瘤杂志(电子版)2010，，03： | 12 |
| 2 | Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer显示文摘 | Van Cutsem E Kōhne C Hitre E | | New England Journal of Medicine0，，： | 3 |
| 3 | Phase Ⅲ study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as fast-line therapy for advanced gastric cancer:a report of the V325 study group显示文摘 | Van Cutsem E Moiseyenko VM Tjulandin S | 2006 | J Clin Oncol2006，24，31： | 1 |
| 4 | Phase Ⅲ study of weekly highdose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group study 40986 显示文摘 | Kohne CH van Cutsem E Wils J | 2005 | J Clin Oncol2005，23，8： | 1 |
| 5 | Current treatments and future perspectives in colorectal and gastric cancer显示文摘 | Wilke HJ Van Cutsem E | 2003 | Ann Oncol2003，142，： | 1 |
| 6 | Raltitrexed: current clinical status and future directions 显示文摘 | Van Cutsem E Cunningham D Maroun J | 2002 | Ann Oncol2002，13，4： | 1 |
| 7 | Cetuximab and chemotherapy as initial treatment for metastatic coloreetal cancer显示文摘 | Van Cutsem E K? hne CH Hitre E | 2009 | N Engl J Med2009，360，14： | 1 |
| 8 | ESMO Consensus Guidelines for management of patients with colon and rectal cancer, a personalized approach to 'clinical decision making 显示文摘 | Schmoll HJ Van Cutsem E Stein A | 2012 | Ann 0ncol2012，23，10： | 1 |
| 9 | Safety and efficacy of first- line bevacizumab with FOLFOX,XELOX,FOLFIRI and fluoropyrim- idines in metastatic colorectal cancer:the BEAT study显示文摘 | Van Cutsem E Rivera F Berry S et a/ | 2009 | Ann Oncol2009，20，11： | 1 |
| 10 | Trastuzurnab in com bination with chemotherapy versus chemotherapy alone for treatment of Her-2-positive advanced gastric or gastro-oesophageal junction cancer (TOGA) : a phase 3, open-label, randomised controlled trial显示文摘 | Bang YJ Van Cutsem E Feyereislova A | 2010 | Lancet2010，376，9742： | 1 |
| 11 | Phase III studyof docetaxel and cisplatin plusfluorouracil compared with cisplatinand f\uorouraci\ as first-line therapyfor advanced gastric cancer: a reportof the V325 Study Group显示文摘 | Van Cutsem E Moiseyenko VM Tjulandin S | 2006 | J ClinOncol''2006，24，31： | 1 |
| 12 | Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, ran- domised, placebo-controlled, phase 3 trial显示文摘 | Grothey A Van Cutsem E Sobrero A | 2013 | Lancet2013，381，9863： | 1 |
| 13 | Trastuzumab in combination with chemotherapy versuschemotherapy alone for treatment of HER2 - positive advancedgastric or gastro - oesophageal junction cancer(ToGA) : A phase 3, open - label, randomised controlledtrial 显示文摘 | BANGYJ VAN CUTSEM E FEYEREISLOVA A | | Lancet0，2010，376： | 1 |
| 14 | Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic coloreetal cancer? A report from the european colorectal metastases treatment group 显示文摘 | Nordlinger B Van Cutsem E Rougier P | 2007 | Eur J Cancer2007，43，14： | 1 |
| 15 | Towards a pan-European consensus on the treatment of patients with colorectal liver metastases 显示文摘 | Van Cutsem E Nordlinger B Adam R | 2006 | Eur J Cancer2006，42，14： | 1 |
| 16 | Phase Ⅲ study of docetaxel and cisplatin plus fluo-rouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer:a report of the V325 Study Group 显示文摘 | Van Cutsem E Moiseyenko VM Tjulandin S | 2006 | J Clin Oncol2006，24，31： | 1 |
| 17 | Phase llI study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first line therapy for advanced gastric cancer: a report of the V325 Study Group 显示文摘 | Van Cutsem E Moiseyenko VM Tjulandin S | 2006 | J Clin Oncol2006，24，31： | 1 |
| 18 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastrooesophageal junction cancer (TOGA) : a phase3, open-label, randomised con- trolled trial显示文摘 | Bang YJ Van Cutsem E Feyereislova A | 2010 | Lancet2010，376，： | 1 |
| 19 | Clinical signs,pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors显示文摘 | Segaert S Van Cutsem E | | 0，，： | 1 |
| 20 | Bevacizumab in com- bination with chemotherapy as first-line therapy in advanced gas- tric Cancer: a randomized, double-hund, placebo-controlled phase Ⅲ study显示文摘 | Ohtsu A Shah MA van Cutsem E | 2011 | J Clin Oncol2011，29，30： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员